Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Hamatologie Und Bluttransfusion
|
January 1, 1976
[Hairy cell leukemia]
H Löffler, A Roux, J Fischer, et al.
Cancer
|
October 1, 1982
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)
H Breithaupt, H Pralle, T Eckhardt, et al.
Lancet (London, England)
|
January 8, 1994
Severe adverse effects of protein A immunoadsorption
A Käbisch, H Kroll, B Wedi, et al.
International Journal of Oncology
|
May 6, 2011
Comparison of different antisense oligonucleotides against the BCR/ABL junction in chronic myelogenous leukemia
A Kaebisch, U Seay, S Wicker, et al.
Strahlentherapie
|
June 1, 1982
[Results of radiotherapy in case of Hodgkin's disease after primary failure of chemotherapy and recurrence after chemotherapy ]
W Gassmann, N Schmitz, M Breidenbach, et al.
Haemostasis
|
August 26, 1999
Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro
A C Matzdorff, D Berchner, G Kühnel, et al.
Cancer Genetics and Cytogenetics
|
July 15, 1993
Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11)
L Li, J Ritterbach, J Harbott, et al.
Sozial- Und Praventivmedizin
|
January 1, 1993
Increased risk of acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML) in a county of Hesse, Germany
G Kolb, N Becker, S Scheller, et al.
British Journal of Haematology
|
April 1, 1985
Staging systems for multiple myeloma: a comparison
W Gassmann, H Pralle, T Haferlach, et al.
The Journal of Laboratory and Clinical Medicine
|
March 11, 2000
Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro
A C Matzdorff, G Kühnel, B Kemkes-Matthes, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Hamatologie Und Bluttransfusion
|
January 1, 1976
[Hairy cell leukemia]
H Löffler, A Roux, J Fischer, et al.
Cancer
|
October 1, 1982
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)
H Breithaupt, H Pralle, T Eckhardt, et al.
Lancet (London, England)
|
January 8, 1994
Severe adverse effects of protein A immunoadsorption
A Käbisch, H Kroll, B Wedi, et al.
International Journal of Oncology
|
May 6, 2011
Comparison of different antisense oligonucleotides against the BCR/ABL junction in chronic myelogenous leukemia
A Kaebisch, U Seay, S Wicker, et al.
Strahlentherapie
|
June 1, 1982
[Results of radiotherapy in case of Hodgkin's disease after primary failure of chemotherapy and recurrence after chemotherapy ]
W Gassmann, N Schmitz, M Breidenbach, et al.
Haemostasis
|
August 26, 1999
Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro
A C Matzdorff, D Berchner, G Kühnel, et al.
Cancer Genetics and Cytogenetics
|
July 15, 1993
Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11)
L Li, J Ritterbach, J Harbott, et al.
Sozial- Und Praventivmedizin
|
January 1, 1993
Increased risk of acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML) in a county of Hesse, Germany
G Kolb, N Becker, S Scheller, et al.
British Journal of Haematology
|
April 1, 1985
Staging systems for multiple myeloma: a comparison
W Gassmann, H Pralle, T Haferlach, et al.
The Journal of Laboratory and Clinical Medicine
|
March 11, 2000
Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro
A C Matzdorff, G Kühnel, B Kemkes-Matthes, et al.
Page
of 11